1. Overview

David Y. Johnson and Frank E. Johnson

2. Introduction to Cancer Surveillance Strategies

Brooke Crawford and David D. Greenberg

3. Using Decision Analysis to Model Cancer Surveillance

Kim E.M. van Kessel, Sandra M.E. Geurts, André L.M. Verbeek, and Ewout W. Steyerberg

4. Cancer Survivorship: Monitoring the Long-Term and Late Effects of Treatment

Craig C. Earle and Jennifer Deevy

5. Upper Aerodigestive Tract Carcinoma

David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson

6. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Europe

Béatrix Barry and Dominique De Raucourt

7. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Japan

Torahiko Nakashima, Ryuji Yasumatsu, and Shizuo Komune

8. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Canada

Richard W. Nason and James B. Butler

9. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma

David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson

10. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Australia

Leigh Delbridge

11. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Japan

Ryuji Yasumatsu, Torahiko Nakashima, and Shizuo Komune

12. Lung Carcinoma

Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson

13. Lung Carcinoma Surveillance Counterpoint: Australia

Michael Boyer and Kate Mahon

14. Lung Carcinoma Surveillance Counterpoint: Japan

Tokujiro Yano and Yoshihiko Maehara

15. Lung Carcinoma Surveillance Counterpoint: Canada

Gail Darling, Yee Ung, Peter Ellis, Lorraine Martelli-Reid, and Bill Evans

16. Esophagus Carcinoma

Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson

17. Esophagus Carcinoma Surveillance Counterpoint: Australia

Bernard Mark Smithers, Janine M. Thomas, and Bryan H. Burmeister

18. Esophagus Carcinoma Surveillance Counterpoint: Japan

Masaru Morita and Yoshihiko Maehara

19. Stomach

Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson

20. Stomach Carcinoma Surveillance Counterpoint: USA

Andrew Coleman and Douglas Tyler

21. Stomach Carcinoma Surveillance Counterpoint: Japan

Yoshihiro Kakeji, Masaru Morita, and Yoshihiko Maehara

22. Pancreatic Adenocarcinoma

David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson

23. Pancreatic Adenocarcinoma Surveillance Counterpoint: USA

Tanios S. Bekaii-Saab

24. Pancreatic Adenocarcinoma Surveillance Counterpoint: Europe

Richard A. Smith, Jane V. Butler, and John P. Neoptolemos

25. Pancreatic Adenocarcinoma Surveillance Counterpoint: Japan

Ken Shirabe and Yoshihiko Maehara

26. Pancreatic Adenocarcinoma Surveillance Counterpoint: Canada

Malcolm J. Moore and Anastasios Stathis

27. Liver and Biliary Tract Carcinoma

David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson

28. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Europe

Michele Colledan

29. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Australia

Michael D. Crawford

30. Liver and Biliary Tract